首页> 中文期刊> 《上海医药》 >活络骨康丸联合利伐沙班对髋关节置换术后35例患者的血流动力学指标的影响研究

活络骨康丸联合利伐沙班对髋关节置换术后35例患者的血流动力学指标的影响研究

         

摘要

目的:探讨活络骨康丸联合利伐沙班对髋关节置换术后患者的血流动力学指标的影响。方法:采用随机数字表法将69例行髋关节置换术的患者分为观察组(35例)和对照组(34例),观察组用活络骨康丸联合利伐沙班治疗,对照组仅用利伐沙班治疗,比较两组患者血流动力学指标的差异。结果:治疗前,两组患者全血高、低切黏度、血浆比黏度、HCT、EET比较差异无统计学意义(P>0.05),治疗后这些指标明显降低、且观察组明显低于对照组(P0.05)。结论:活络骨康丸联合利伐沙班可显著改善髋关节置换术后患者的血流动力学指标,稍降低下肢深静脉血栓发生风险,且不增加出血风险。%Objective:To study the effect of Huoluo Gukang pill combined with rivaroxaban on the hemodynamic parameters of the patients with hip replacement surgery.Methods: Sixty-nine cases of the patients with hip replacement surgery were divided into an observation group (n=35) and a control group (n=34) by the random number table method. The observation group was treated by Huoluo Gukang pill combined with rivaroxaban therapy while the control group only by rivaroxaban therapy. The differences of hemodynamic parameters between the two groups were compared.Results: The comparison of whole blood high and low shear viscosity, plasma speciifc viscosity, HCT and EET showed no statistical signiifcance (P>0.05) between the two groups before treatment. These indexes were all decreased after treatment and furthermore they were obviously lower in the observation group than the control group (P0.05).Conclusion: Huoluo Gukang pill combined with rivaroxaban can slightly reduce the risk of the occurrence of lower extremity deep vein thrombosis by signiifcantly improving hemodynamic parameters without increasing the risk of bleeding.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号